Effect of 5-HT3 receptor antagonist MDL 72222 on behaviors induced by ketamine in rats and mice

European Neuropsychopharmacology

Volumn 16, Issue 4, 2006, Pages 297-310

  Kos, T ^a   Popik, P ^a   Pietraszek, M ^a,b   Schafer D ^b   Danysz, W ^b   Dravolina, O ^c   Blokhina, E ^c   Galankin, T ^c   Bespalov, A Y ^c  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

^b MERZ PHARMACEUTICALS GMBH   (Germany)

^c PAVLOV FIRST SAINT PETERSBURG STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

5 HT3 receptor antagonist; Antidepressant like action; Cognitive effects; Drug discrimination; NMDA receptor antagonist; Prepulse inhibition

Indexed keywords

BEMESETRON; KETAMINE; SEROTONIN 3 ANTAGONIST; AMINO ACID RECEPTOR BLOCKING AGENT; SEROTONIN 3 RECEPTOR; SEROTONIN ANTAGONIST; TROPANE DERIVATIVE;

ACCURACY; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATAXIA; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DRUG EFFECT; EXPLORATORY BEHAVIOR; MALE; MOUSE; NONHUMAN; PREPULSE INHIBITION; PRIORITY JOURNAL; RAT; STARTLE REFLEX; STEREOTYPY; TAIL; ANIMAL; C57BL MOUSE; COMPARATIVE STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG INTERACTION; IMMOBILIZATION; INSTRUMENTAL CONDITIONING; METHODOLOGY; MOTOR ACTIVITY; NERVE CELL INHIBITION; PERCEPTIVE DISCRIMINATION; REACTION TIME; SPRAGUE DAWLEY RAT; WISTAR RAT;

ANIMALS; BEHAVIOR, ANIMAL; CONDITIONING, OPERANT; DISCRIMINATION (PSYCHOLOGY); DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; EXCITATORY AMINO ACID ANTAGONISTS; EXPLORATORY BEHAVIOR; HINDLIMB SUSPENSION; KETAMINE; MALE; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; NEURAL INHIBITION; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; REACTION TIME; RECEPTORS, SEROTONIN, 5-HT3; SEROTONIN ANTAGONISTS; TROPANES;

EID: 33645977758     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2005.10.001     Document Type: Article

References (44)

1. Ballard T.M., and Mcallister K.H. The NMDA antagonist EAA 494 does not impair working memory in an operant DNMTP task in rats. Pharmacol. Biochem. Behav. 65 (2000) 725-730
2. Berman R.M., Cappiello A., Anand A., Oren D.A., Heninger G.R., Charney D.S., and Krystal J.H. Antidepressant effects of ketamine in depressed patients. Biol. Psychiatry 47 (2000) 351-354
3. Boast C., Bartolomeo A.C., Morris H., and Moyer J.A. 5HT antagonists attenuate MK801-impaired radial arm maze performance in rats. Neurobiol. Learn. Mem. 71 (1999) 259-271
4. Bourin M., Redrobe J.P., and Baker G.B. Pindolol does not act only on 5-HT1A receptors in augmenting antidepressant activity in the mouse forced swimming test. Psychopharmacology (Berl) 136 (1998) 226-234
5. Braff D.L., Geyer M.A., and Swerdlow N.R. Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology (Berl) 156 (2001) 234-258
6. Breese G.R., Knapp D.J., and Moy S.S. Integrative role for serotonergic and glutamatergic receptor mechanisms in the action of NMDA antagonists: potential relationships to antipsychotic drug actions on NMDA antagonist responsiveness. Neurosci. Biobehav. Rev. 26 (2002) 441-455
7. Breier A., Malhotra A.K., Pinals D.A., Weisenfeld N.I., and Pickar D. Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers. Am. J. Psychiatry 154 (1997) 805-811
8. Chaturvedi H.K., Chandra D., and Bapna J.S. Effect of NMDA antagonists in forced swimming test and its modification by antidepressants. Indian J. Pharmacol. 31 (1999) 104-109
9. Clissold D.B., Karbon E.W., Ferkany J.W., Hartman T., and Pontecorvo M.J. Effects of strychnine-insensitive glycine receptor antagonists and sigma agents on working memory performance: comparison with dizocilpine and scopolamine. Behav. Pharmacol. 3 (1992) 393-402
10. Cole B.J., Klewer M., Jones G.H., and Stephens D.N. Contrasting effects of the competitive NMDA antagonist CPP and the non- competitive NMDA antagonist MK 801 on performance of an operant delayed matching to position task in rats. Psychopharmacology (Berl) 111 (1993) 465-471
11. Danysz W., Essmann U., Bresink I., and Wilke R. Glutamate antagonists have different effects on spontaneous locomotor activity in rats. Pharmacol. Biochem. Behav. 48 (1994) 111-118
12. De Vry J., and Jentzsch K.R. Role of the NMDA receptor NR2B subunit in the discriminative stimulus effects of ketamine. Behav. Pharmacol. 14 (2003) 229-235
13. Diez-Ariza M., Redondo C., Garcia-Alloza M., Lasheras B., Del Rio J., and Ramirez M.J. Flumazenil and tacrine increase the effectiveness of ondansetron on scopolamine-induced impairment of spatial learning in rats. Psychopharmacology (Berl) 169 (2003) 35-41
14. Evoniuk G.E., Hertzman R.P., and Skolnick P. A rapid method for evaluating the behavioral effects of phencyclidine-like dissociative anesthetics in mice. Psychopharmacology 105 (1991) 125-128
15. Genovese R.F., and Lu X.C. Effects of MK-801 stereoisomers on schedule-controlled behavior in rats. Psychopharmacology (Berl) 105 (1991) 477-480
16. Geyer M.A., Krebs-Thomson K., Braff D.L., and Swerdlow N.R. Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology (Berl) 156 (2001) 117-154
17. Ginski M.J., and Witkin J.M. Sensitive and rapid behavioral differentiation of N-methyl-d- aspartate receptor antagonists. Psychopharmacology 114 (1994) 573-582
18. Irifune M., Shimizu T., Nomoto M., and Fukuda T. Involvement of N-methyl-d-aspartate (NMDA) receptors in noncompetitive NMDA receptor antagonist-induced hyperlocomotion in mice. Pharmacol. Biochem. Behav. 51 (1995) 291-296
19. Joharchi N., Sellers E.M., and Higgins G.A. Effect of 5-HT3 receptor antagonists on the discriminative stimulus properties of morphine in rats. Psychopharmacology 112 (1993) 111-115
20. Kos T., and Popik P. A comparison of the predictive therapeutic and undesired side-effects of NMDA receptor antagonist, memantine in mice. Behav. Pharmacol. 16 (2005) 155-161
21. Krystal J.H., Karper L.P., Seibyl J.P., Freeman G.K., Delaney R., Bremner J.D., Heninger G.R., Bowers M.B., and Charney D.S. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch. Gen. Psychiatry 51 (1994) 199-214
22. Mantovani M., Pertile R., Calixto J.B., Santos A.R., and Rodrigues A.L. Melatonin exerts an antidepressant-like effect in the tail suspension test in mice: evidence for involvement of N-methyl-d-aspartate receptors and the l-arginine-nitric oxide pathway. Neurosci. Lett. 343 (2003) 1-4
23. Martin P., Gozlan H., and Puech A.J. 5-HT3 receptor antagonists reverse helpless behaviour in rats. Eur. J. Pharmacol. 212 (1992) 73-78
24. McCool B.A., and Lovinger D.M. Ifenprodil inhibition of the 5-hydroxytryptamine3 receptor. Neuropharmacology 34 (1995) 621-629
25. Nakagawa Y., Ishima T., and Takashima T. The 5-HT3 receptor agonist attenuates the action of antidepressants in the forced swim test in rats. Brain Res. 786 (1998) 189-193
26. Nestler E.J., Barrot M., DiLeone R.J., Eisch A.J., Gold S.J., and Monteggia L.M. Neurobiology of depression. Neuron 34 (2002) 13-25
27. O'Neil M.F., and Moore N.A. Animal models of depression: are there any?. Hum. Psychopharmacol. 18 (2003) 239-254
28. Ohno M., and Watanabe S. Differential effects of 5-HT3 receptor antagonism on working memory failure due to deficiency of hippocampal cholinergic and glutamatergic transmission in rats. Brain Res. 762 (1997) 211-215
29. Paris J.M., and Cunningham K.A. Serotonin 5-HT3 antagonists do not alter the discriminative stimulus properties of cocaine. Psychopharmacology (Berl) 104 (1991) 475-478
30. Parsons C.G., Danysz W., and Quack G. Memantine is a clinically well tolerated N-methyl-d-aspartate (NMDA) receptor antagonist-A review of preclinical data. Neuropharmacology 38 (1999) 735-767
31. Pietraszek M., Gravius A., Schafer D., Weil T., Trifanova D., and Danysz W. mGluR5, but not mGluR1, antagonist modifies MK-801-induced locomotor activity and deficit of prepulse inhibition. Neuropharmacology 49 (2005) 73-85
32. Rammes G., Rupprecht R., Ferrari U., Zieglgansberger W., and Parsons C.G. The N-methyl-d-aspartate receptor channel blockers memantine, MRZ 2/579 and other amino-alkyl-cyclohexanes antagonise 5-HT3 receptor currents in cultured HEK-293 and N1E-115 cell systems in a non-competitive manner. Neurosci. Lett. 306 (2001) 81-84
33. Rammes G., Eisensamer B., Ferrari U., Shapa M., Gimpl G., Gilling K., Parsons C., Riering K., Hapfelmeier G., Bondy B., Zieglgansberger W., Holsboer F., and Rupprecht R. Antipsychotic drugs antagonize human serotonin type 3 receptor currents in a noncompetitive manner. Mol. Psychiatry 9 (2004) 846-858
34. Sirota P., Mosheva T., Shabtay H., Giladi N., and Korczyn A.D. Use of the selective serotonin 3 receptor antagonist ondansetron in the treatment of neuroleptic-induced tardive dyskinesia. Am. J. Psychiatry 157 (2000) 287-289
35. Sofia R.D., and Harakal J.J. Evaluation of ketamine HCl for anti-depressant activity. Arch. Int. Pharmacodyn. Ther. 214 (1975) 68-74
36. Stefanski R., Bienkowski P., and Kostowski W. Studies on the role of 5-HT3 receptors in the mediation of the ethanol interoceptive cue. Eur. J. Pharmacol. 309 (1996) 141-147
37. Steru L., Chermat R., Thierry B., and Simon P. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology 85 (1985) 367-370
38. Trullas R., and Skolnick P. Functional antagonists at the NMDA receptor complex exhibit antidepressant actions. Eur.J.Pharmacol. 185 (1990) 1-10
39. Varty G.B., Bakshi V.P., and Geyer M.A. M100907, a serotonin 5-HT2a receptor antagonist and putative antipsychotic, blocks dizocilpine-induced prepulse inhibition deficits in Sprague-Dawley and Wistar rats. Neuropsychopharmacology 20 (1999) 311-321
40. Willmore C.B., Bespalov A.Y., and Beardsley P.M. Competitive and noncompetitive NMDA antagonist effects in rats trained to discriminate lever-press counts. Pharmacol. Biochem. Behav. 69 (2001) 493-502
41. Willmore C.B., Bespalov A.Y., and Beardsley P.M. Site-selective N-methyl-d-aspartate and alpha-amino-3-hydroxy-5-methyl- 4-isoxazolepropionate antagonists produce distinct effects in rats performing complex discriminations. Neurobiol. Learn. Mem. 78 (2002) 347-364
42. Yilmaz A., Schulz D., Aksoy A., and Canbeyli R. Prolonged effect of an anesthetic dose of ketamine on behavioral despair. Pharmacol. Biochem. Behav. 71 (2002) 341-344
43. Zhang J., Engel J.A., Jackson D.M., Johansson C., and Svensson L. (-)Alprenolol potentiates the disrupting effects of dizocilpine on sensorimotor function in the rat. Psychopharmacology (Berl) 132 (1997) 281-288
44. Zoldan J., Friedberg G., Livneh M., and Melamed E. Psychosis in advanced Parkinson's disease: treatment with ondansetron, a 5-HT3 receptor antagonist. Neurology 45 (1995) 1305-1308